Hanmi Group "If You Achieve Results, We'll Give You Stocks" Establishing a Global-Level Compensation System

[Financial News] Hanmi Group, after transitioning to a new professional management system, is accelerating its entry into the global market and is set to revamp its compensation system to secure top-tier global talent. Hanmi Group's holding company Hanmi Science and its core business company Hanmi Pharmaceutical announced on the 1st that they will introduce a 'stock-based performance compensation system' aimed at employees, which focuses on instilling a genuine sense of ownership among employees and enhancing motivation to achieve the company's mid- to long-term goals.
This system is a strategic decision by the company to recruit talent with excellent competitiveness and establish a global-level performance compensation system, through which they plan to provide stronger motivation to employees and further solidify a performance-oriented organizational culture.
The stock-based compensation system will primarily operate in two ways: 'RSA (Restricted Stock Award)' and 'RSU (Restricted Stock Unit)'.
RSA allows employees to receive existing PI (Performance Incentives) in the form of company stocks, where employees can choose to receive 50~100% of the PI amount as company stocks based on semi-annual evaluation results. Any potential losses from stock price declines during this process will be separately compensated by the company to reduce the burden on employees.
RSU is a reward for contributions to the company's long-term value increase, such as significant increases in sales or profits, new drug approvals, and technology exports, which have a major impact on enhancing corporate value. Employees who contribute to these achievements will be awarded company stocks equivalent to up to 100% of their annual salary.
This system will apply to employees of major affiliates such as Hanmi Science, Hanmi Pharmaceutical, the healthcare distribution subsidiary Online Pharm, and the API (Active Pharmaceutical Ingredient) specialized affiliate Hanmi Fine Chemical, who are employed at the time of implementation, excluding major shareholders.
Hanmi expects that through this compensation system, the company and employees can focus on shared goals and share achievements, thereby establishing a sustainable growth foundation. The implementation of the system will be finalized after the board of directors' resolution following the confirmation of detailed operational plans.
Kim Jae-kyo, CEO of Hanmi Science, said, "In the fiercely competitive pharmaceutical and bio industry, a performance-oriented compensation system is an essential condition for securing the company's future competitiveness," adding, "Through this system, we will attract global top talent and establish a culture where all employees have a sense of ownership and grow together, realizing sustainable corporate value."

vrdw88@fnnews.com Kang Jung-mo Reporter